Research output per year
Research output per year
Personal profile
Clinical interests
Medical oncology, breast cancer, breast oncology
Fingerprint
Dive into the research topics where Andrew Davis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial
Gerratana, L., Kocherginsky, M., Davis, A. A., D’Amico, P., Reduzzi, C., Puglisi, F. & Cristofanilli, M., Feb 2024, In: Oncologist. 29, 2, p. 123-131 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Applications for Liquid Biopsy Assessment of Minimal Residual Disease in Breast Cancer
Sears, J. J. & Davis, A. A., Sep 2023, In: Current Breast Cancer Reports. 15, 3, p. 252-265 14 p.Research output: Contribution to journal › Review article › peer-review
-
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Hensing, W. L., Gerratana, L., Clifton, K., Medford, A. J., Velimirovic, M., Shah, A. N., Amico, P. D., Reduzzi, C., Zhang, Q., Dai, C. S., Denault, E. N., Bagegni, N. A., Opyrchal, M., Ademuyiwa, F. O., Bose, R., Behdad, A., Ma, C. X., Bardia, A., Cristofanilli, M. & Davis, A. A., Aug 15 2023, In: Clinical Cancer Research. 29, 16, p. 3092-3100 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HRþ)/HER2-Negative Metastatic Breast Cancer
Davis, A. A., Luo, J., Zheng, T., Dai, C., Dong, X., Tan, L., Suresh, R., Ademuyiwa, F. O., Rigden, C., Rearden, T. P., Clifton, K., Weilbaecher, K., Frith, A., Tandra, P. K., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L. F., Peterson, L. L. & Wang, X. & 7 others, , May 1 2023, In: Clinical Cancer Research. 29, 9, p. 1719-1729 11 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
Gerratana, L., Davis, A. A., Velimirovic, M., Clifton, K., Hensing, W. L., Shah, A. N., Dai, C. S., Reduzzi, C., D’Amico, P., Wehbe, F., Medford, A., Wander, S. A., Gradishar, W. J., Behdad, A., Puglisi, F., Ma, C. X., Bardia, A. & Cristofanilli, M., Dec 2023, In: Breast Cancer Research. 25, 1, 112.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations